SONA — Sona Nanotech Share Price
Last trade - 00:00- CA$26.77m
- CA$27.30m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 54.31 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -307.86% | ||
| Return on Equity | -214.41% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Oct | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.
Directors
- Daniel Whittaker NEC
- Darren Rowles PRE (40)
- David Regan CEO (51)
- Robert Randall CFO
- James Megann DRC
- Michael Gross IND
- John Lievonen IND
- Robert McKay IND
- Last Annual
- October 31st, 2023
- Last Interim
- April 30th, 2024
- Incorporated
- August 8th, 2018
- Public Since
- October 4th, 2018
- No. of Employees
- 8
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Canadian Securities Exchange
- Shares in Issue
- 99,145,361
- Address
- Purdy's Wharf Tower 2, HALIFAX, B3J 3R7
- Web
- https://www.sonanano.com/
- Phone
- +1 9024420653
- Auditors
- Manning Elliott LLP
Upcoming Events for SONA
Similar to SONA
Albert Labs International
Canadian Securities Exchange
Algernon Pharmaceuticals
Canadian Securities Exchange
Alpha Cognition
Canadian Securities Exchange
Asep Medical Holdings
Canadian Securities Exchange
Awakn Life Sciences
Canadian Securities Exchange
FAQ
As of Today at 23:21 UTC, shares in Sona Nanotech are trading at CA$0.27. This share price information is delayed by 15 minutes.
Shares in Sona Nanotech last closed at CA$0.27 and the price had moved by +35% over the past 365 days. In terms of relative price strength the Sona Nanotech share price has outperformed the Toronto Stock Exchange 300 Composite Index by +18.96% over the past year.
The overall consensus recommendation for Sona Nanotech is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreSona Nanotech does not currently pay a dividend.
Sona Nanotech does not currently pay a dividend.
Sona Nanotech does not currently pay a dividend.
To buy shares in Sona Nanotech you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.27, shares in Sona Nanotech had a market capitalisation of CA$26.77m.
Here are the trading details for Sona Nanotech:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: SONA
Based on an overall assessment of its quality, value and momentum Sona Nanotech is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sona Nanotech. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -35.5%.
As of the last closing price of CA$0.27, shares in Sona Nanotech were trading -12.53% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Sona Nanotech PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.27.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Sona Nanotech's management team is headed by:
- Daniel Whittaker - NEC
- Darren Rowles - PRE
- David Regan - CEO
- Robert Randall - CFO
- James Megann - DRC
- Michael Gross - IND
- John Lievonen - IND
- Robert McKay - IND